相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Disparities in cause-specific mortality by race and sex among bladder cancer patients from the SEER database
Timothy D. D. Shu et al.
CANCER CAUSES & CONTROL (2023)
Physical activity, obesity, and bladder cancer incidence
Sicha Chantaprasopsuk et al.
CANCER CAUSES & CONTROL (2023)
Tobacco Product Use Among Adults – United States, 2021
Monica E. Cornelius et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2023)
Surveillance of Low-Grade Non-Muscle Invasive Bladder Tumors Using Uromonitor: SOLUSION Trial
Nessn Azawi et al.
CANCERS (2023)
Cancer statistics, 2023
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2023)
Bladder Cancer and Risk Factors: Data from a Multi-Institutional Long-Term Analysis on Cardiovascular Disease and Cancer Incidence
Biagio Barone et al.
JOURNAL OF PERSONALIZED MEDICINE (2023)
The Diagnostic Accuracy of Cystoscopy for Detecting Bladder Cancer in Adults Presenting with Haematuria: A Systematic Review from the European Association of Urology Guidelines Office
Wout Devlies et al.
European Urology Focus (2023)
Urinary biomarkers for bladder cancer diagnosis and NMIBC follow-up: a systematic review
Yanish Soorojebally et al.
WORLD JOURNAL OF UROLOGY (2023)
European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ)
Marko Babjuk et al.
EUROPEAN UROLOGY (2022)
The Development of Non-Invasive Diagnostic Tools in Bladder Cancer
Alison Schulz et al.
ONCOTARGETS AND THERAPY (2022)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Surveillance Intensity in Intermediate Risk, Nonmuscle Invasive Bladder Cancer: Revisiting the Optimal Timing and Frequency of Cystoscopy
Abhishek Bhat et al.
JOURNAL OF UROLOGY (2021)
Retrospective German claims data study on initial treatment of bladder carcinoma (BCa) by transurethral bladder resection (TURB): a comparative analysis of costs using standard white light- (WL-) vs. blue light- (BL-) TURB
Tilman Todenhofer et al.
WORLD JOURNAL OF UROLOGY (2021)
Biomarkers in Bladder Cancer Surveillance
Sukumar S. Sugeeta et al.
FRONTIERS IN SURGERY (2021)
Keratin 17 Is a Novel Cytologic Biomarker for Urothelial Carcinoma Diagnosis
Sruthi Babu et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2021)
Use and Validation of the AUA/SUO Risk Grouping for Nonmuscle Invasive Bladder Cancer in a Contemporary Cohort
Chad R. Ritch et al.
JOURNAL OF UROLOGY (2020)
An evaluation of the real world use and clinical utility of the Cxbladder Monitor assay in the follow-up of patients previously treated for bladder cancer
Madhusudan Koya et al.
BMC UROLOGY (2020)
Association between Smoking Exposure, Neoadjuvant Chemotherapy Response and Survival Outcomes following Radical Cystectomy: Systematic Review and Meta-Analysis
G. E. Cacciamani et al.
JOURNAL OF UROLOGY (2020)
Medical Care Costs Associated with Cancer Survivorship in the United States
Angela B. Mariotto et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2020)
Microhematuria: AUA/SUFU Guideline
Daniel A. Barocas et al.
JOURNAL OF UROLOGY (2020)
Bladder Cancer: A Review
Andrew T. Lenis et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Urinary biomarkers in bladder cancer: where do we stand?
Abhishek Bhat et al.
CURRENT OPINION IN UROLOGY (2019)
Bladder Cancer Diagnosis and Follow-Up: The Current Status and Possible Role of Extracellular Vesicles
Eline Oeyen et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Molecular markers in bladder cancer
Francesco Soria et al.
WORLD JOURNAL OF UROLOGY (2019)
Processed Meat Intake and Bladder Cancer Risk in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cohort
Xin Xu
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2019)
Non-visible haematuria for the Detection of Bladder, Upper Tract, and Kidney Cancer: An Updated Systematic Review and Meta-analysis
Ibrahim Jubber et al.
EUROPEAN UROLOGY (2019)
Modeling the Complex Exposure History of Smoking in Predicting Bladder Cancer A Pooled Analysis of 15 Case-Control Studies
Frits H. M. van Osch et al.
EPIDEMIOLOGY (2019)
Keratin 17 is a sensitive and specific biomarker of urothelial neoplasia
Sruthi Babu et al.
MODERN PATHOLOGY (2019)
Progress towards a Nordic standard for the investigation of hematuria: 2019
Per-Uno Malmstrom et al.
SCANDINAVIAN JOURNAL OF UROLOGY (2019)
Validation of a Novel, Sensitive, and Specific Urine-Based Test for Recurrence Surveillance of Patients With Non-Muscle-Invasive Bladder Cancer in a Comprehensive Multicenter Study
Rui Batista et al.
FRONTIERS IN GENETICS (2019)
Epidemiology, aetiology and screening of bladder cancer
Marcus G. K. Cumberbatch et al.
TRANSLATIONAL ANDROLOGY AND UROLOGY (2019)
Red and processed meat consumption and risk of bladder cancer: a dose-response meta-analysis of epidemiological studies
Alessio Crippa et al.
EUROPEAN JOURNAL OF NUTRITION (2018)
Nationwide analysis on the impact of socioeconomic land use factors and incidence of urothelial carcinoma
Maximilian P. Brandt et al.
CANCER EPIDEMIOLOGY (2018)
Can Renal and Bladder Ultrasound Replace Computerized Tomography Urogram in Patients Investigated for Microscopic Hematuria?
Wei Shen Tan et al.
JOURNAL OF UROLOGY (2018)
An up-to-date catalog of available urinary biomarkers for the surveillance of non-muscle invasive bladder cancer
Francesco Soria et al.
WORLD JOURNAL OF UROLOGY (2018)
Occupational Exposure to Polycyclic Aromatic Hydrocarbons and Elevated Cancer Incidence in Firefighters
Anna A. Stec et al.
SCIENTIFIC REPORTS (2018)
Clinical Utility of Cxbladder Monitor for Patients with a History of Urothelial Carcinoma: A Physician-Patient Real-World Clinical Data Analysis
Tony Lough et al.
ONCOLOGY AND THERAPY (2018)
Elevated Exposures to Polycyclic Aromatic Hydrocarbons and Other Organic Mutagens in Ottawa Firefighters Participating in Emergency, On-Shift Fire Suppression
Jennifer L. A. Keir et al.
ENVIRONMENTAL SCIENCE & TECHNOLOGY (2017)
EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016
Marko Babjuk et al.
EUROPEAN UROLOGY (2017)
Validation of a DNA Methylation-Mutation Urine Assay to Select Patients with Hematuria for Cystoscopy
Kim E. M. van Kessel et al.
JOURNAL OF UROLOGY (2017)
Clinical comparison of noninvasive urine tests for ruling out recurrent urothelial carcinoma
Yair Lotan et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2017)
Evaluation of the NMP22 BladderChek test for detecting bladder cancer: a systematic review and meta-analysis
Zijie Wang et al.
ONCOTARGET (2017)
A meta-analysis of narrow band imaging for the diagnosis and therapeutic outcome of non-muscle invasive bladder cancer
YiQuan Xiong et al.
PLOS ONE (2017)
The contemporary role and impact of urine-based biomarkers in bladder cancer
Igor Duquesne et al.
TRANSLATIONAL ANDROLOGY AND UROLOGY (2017)
The Value of the UroVysion® FISH Assay in the Risk-Stratification of Patients with Atypical Urothelial Cells in Urinary Cytology Specimens
Renu K. Virk et al.
DIAGNOSTIC CYTOPATHOLOGY (2017)
Clinical Utility of Cxbladder for the Diagnosis of Urothelial Carcinoma
David Darling et al.
ADVANCES IN THERAPY (2017)
Cancer survival in Qidong between 1972 and 2011: A population-based analysis
Jian-Guo Chen et al.
MOLECULAR AND CLINICAL ONCOLOGY (2017)
Anticipatory Positive Urine Tests for Bladder Cancer
Ajay Gopalakrishna et al.
ANNALS OF SURGICAL ONCOLOGY (2017)
Novel fluorescence in situ hybridization-based definition of bacille Calmette-Guerin (BCG) failure for use in enhancing recruitment into clinical trials of intravesical therapies
Ashish M. Kamat et al.
BJU INTERNATIONAL (2016)
Quantified relations between exposure to tobacco smoking and bladder cancer risk: a meta-analysis of 89 observational studies
Frits H. M. van Osch et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2016)
Evaluation of an Epigenetic Profile for the Detection of Bladder Cancer in Patients with Hematuria
Kim E. M. van Kessel et al.
JOURNAL OF UROLOGY (2016)
Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer: AUA/SUO Guideline
Sam S. Chang et al.
JOURNAL OF UROLOGY (2016)
ImmunoCyt test compared to cytology in the diagnosis of bladder cancer: A meta-analysis
Houguang He et al.
ONCOLOGY LETTERS (2016)
Urinary Biomarkers for Diagnosis of Bladder Cancer A Systematic Review and Meta-analysis
Roger Chou et al.
ANNALS OF INTERNAL MEDICINE (2015)
Molecular Markers for Bladder Cancer Screening, Early Diagnosis, and Surveillance: The WHO/ICUD Consensus
Bernd J. Schmitz-Draeger et al.
UROLOGIA INTERNATIONALIS (2015)
Contemporary Occupational Carcinogen Exposure and Bladder Cancer A Systematic Review and Meta-analysis
Marcus G. K. Cumberbatch et al.
JAMA ONCOLOGY (2015)
Sex Disparities in Diagnosis of Bladder Cancer After Initial Presentation With Hematuria A Nationwide Claims-Based Investigation
Joshua A. Cohn et al.
CANCER (2014)
A Panel of Three Markers Hyper- and Hypomethylated in Urine Sediments Accurately Predicts Bladder Cancer Recurrence
Sheng-Fang Su et al.
CLINICAL CANCER RESEARCH (2014)
Bladder tumour antigen (BTA stat) test compared to the urine cytology in the diagnosis of bladder cancer: A meta-analysis
Aiye Guo et al.
CUAJ-Canadian Urological Association Journal (2014)
Testosterone Changes Bladder and Kidney Structure in Juvenile Male Rats
Linda M. Dairiki Shortliffe et al.
JOURNAL OF UROLOGY (2014)
Mortality and cancer incidence in a pooled cohort of US firefighters from San Francisco, Chicago and Philadelphia (1950-2009)
Robert D. Daniels et al.
OCCUPATIONAL AND ENVIRONMENTAL MEDICINE (2014)
Do differences in clinical symptoms and referral patterns contribute to the gender gap in bladder cancer?
Armin Henning et al.
BJU INTERNATIONAL (2013)
Who should be included in a clinical trial of screening for bladder cancer? A decision analysis of data from the prostate, lung, colorectal, and ovarian cancer screening trial
Andrew J. Vickers et al.
CANCER (2013)
Dietary consumption and diet diversity and risk of developing bladder cancer: results from the South and East China case-control study
Fatima Isa et al.
CANCER CAUSES & CONTROL (2013)
Evaluation of UroVysion and Cytology for Bladder Cancer Detection
Haythem Dimashkieh et al.
CANCER CYTOPATHOLOGY (2013)
Screening for Bladder Cancer: Rationale, Limitations, Whom to Target, and Perspectives
Stephane Larre et al.
EUROPEAN UROLOGY (2013)
Reflex ImmunoCyt Testing for the Diagnosis of Bladder Cancer in Patients with Atypical Urine Cytology
Anobel Y. Odisho et al.
EUROPEAN UROLOGY (2013)
Photodynamic Diagnosis of Non-muscle-invasive Bladder Cancer with Hexaminolevulinate Cystoscopy: A Meta-analysis of Detection and Recurrence Based on Raw Data
Maximilian Burger et al.
EUROPEAN UROLOGY (2013)
Understanding the Gender Disparity in Bladder Cancer Risk: The Impact of Sex Hormones and Liver on Bladder Susceptibility to Carcinogens
YUESHENG ZHANG
JOURNAL OF ENVIRONMENTAL SCIENCE AND HEALTH PART C-ENVIRONMENTAL CARCINOGENESIS & ECOTOXICOLOGY REVIEWS (2013)
Cost-Effectiveness of Fluorescence In Situ Hybridization in Patients with Atypical Cytology for the Detection of Urothelial Carcinoma
Bishoy A. Gayed et al.
JOURNAL OF UROLOGY (2013)
Urinary Markers/Cytology What and When Should a Urologist Use
Jeffrey M. Tomasini et al.
UROLOGIC CLINICS OF NORTH AMERICA (2013)
Gender-specific differences in muscle-invasive bladder cancer: the concept of sex steroid sensitivity
Georgios Gakis et al.
WORLD JOURNAL OF UROLOGY (2013)
Expression of androgen and oestrogen receptors and its prognostic significance in urothelial neoplasm of the urinary bladder
Hiroshi Miyamoto et al.
BJU INTERNATIONAL (2012)
The Role of the Androgen Receptor in the Development and Progression of Bladder Cancer
Yi Li et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2012)
Androgen Receptor Signaling Regulates Cell Growth and Vulnerability to Doxorubicin in Bladder Cancer
Masaki Shiota et al.
JOURNAL OF UROLOGY (2012)
A Multigene Urine Test for the Detection and Stratification of Bladder Cancer in Patients Presenting with Hematuria
Paul O'Sullivan et al.
JOURNAL OF UROLOGY (2012)
Diagnosis, Evaluation and Follow-Up of Asymptomatic Microhematuria (AMH) in Adults: AUA Guideline
Rodney Davis et al.
JOURNAL OF UROLOGY (2012)
Long-term Cancer-specific Survival in Patients with High-risk, Non-muscle-invasive Bladder Cancer and Tumour Progression: A Systematic Review
Sven van den Bosch et al.
EUROPEAN UROLOGY (2011)
Association Between Smoking and Risk of Bladder Cancer Among Men and Women
Neal D. Freedman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Sex-specific hormone receptors in urothelial carcinomas of the human urinary bladder: A comparative analysis of clinicopathological features and survival outcomes according to receptor expression
Can Tuygun et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2011)
Occupation and cancer in Britain
L. Rushton et al.
BRITISH JOURNAL OF CANCER (2010)
Delays in Diagnosis and Bladder Cancer Mortality
Brent K. Hollenbeck et al.
CANCER (2010)
Clinical usefulness of fluorescence in situ hybridization for diagnosis and surveillance of bladder cancer
Min-Jung Song et al.
CANCER GENETICS AND CYTOGENETICS (2010)
Hypertension, diuretics and antihypertensives in relation to bladder cancer
Xuejuan Jiang et al.
CARCINOGENESIS (2010)
Prospective Validation of the Clinical Usefulness of Reflex Fluorescence In Situ Hybridization Assay in Patients With Atypical Cytology for the Detection of Urothelial Carcinoma of the Bladder
Bruce J. Schlomer et al.
JOURNAL OF UROLOGY (2010)
Molecular screening for bladder cancer: progress and potential
Anirban P. Mitra et al.
NATURE REVIEWS UROLOGY (2010)
Molecular Pathogenesis and Diagnostics of Bladder Cancer
Anirban P. Mitra et al.
ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE (2009)
Sex and Racial Differences in Bladder Cancer Presentation and Mortality in the US
Emil Scosyrev et al.
CANCER (2009)
Reflex UroVysion Testing in Suspicious Urine Cytology Cases
Susana Ferra et al.
CANCER CYTOPATHOLOGY (2009)
The prognostic value of cytology and fluorescence in situ hybridization in the follow-up of nonmuscle-invasive bladder cancer after intravesical Bacillus Calmette-Guerin therapy
Spasenija Savic et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Economic aspects of bladder cancer: what are the benefits and costs?
K. D. Sievert et al.
WORLD JOURNAL OF UROLOGY (2009)
Occupation and bladder cancer in a hospital-based case-control study in Spain
C. M. Samanic et al.
OCCUPATIONAL AND ENVIRONMENTAL MEDICINE (2008)
Screening for bladder cancer: a perspective
Yair Lotan et al.
WORLD JOURNAL OF UROLOGY (2008)
Surveillance of patients with bladder carcinoma using fluorescent in-situ hybridization on bladder washings
Jonathan Bergman et al.
BJU INTERNATIONAL (2008)
Challenges of cancer biomarker profiling
Karim Bensalah et al.
EUROPEAN UROLOGY (2007)
Guideline for the management of nonmuscle invasive bladder cancer (Stages Ta, T1, and Tis): 2007 update
M. Craig Hall et al.
JOURNAL OF UROLOGY (2007)
Improved detection of bladder carcinoma cells in voided urine by standardized microsatellite analysis
Simona Frigerio et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
UroVysion compared with cytology and quantitative cytology in the surveillance of non-muscle-invasive bladder cancer
Paula M. J. Moonen et al.
EUROPEAN UROLOGY (2007)
Validation of the diagnostic value of NMP22® BladderChek® test as a marker for bladder cancer by photodynamic diagnosis
Stefan Tritschler et al.
EUROPEAN UROLOGY (2007)
Molecular pathways in invasive bladder cancer: New insights into mechanisms, progression, and target identification
Anirban P. Mitra et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Superficial and muscle-invasive bladder cancer: Principles of management for outcomes assessments
Dipen J. Parekh et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Racial disparity in bladder cancer: Trends in tumor presentation at diagnosis
Cheryl T. Lee et al.
JOURNAL OF UROLOGY (2006)
Variability in the performance of nuclear matrix protein 22 for the detection of bladder cancer
Shahrokh F. Shariat et al.
JOURNAL OF UROLOGY (2006)
Comparative outcomes of bladder cancer
Marylou Cardenas-Turanzas et al.
OBSTETRICS AND GYNECOLOGY (2006)
Institutional variability in the accuracy of urinary cytology for predicting recurrence of transitional cell carcinoma of the bladder
PI Karakiewicz et al.
BJU INTERNATIONAL (2006)
Gender and geographic influence on the racial disparity in bladder cancer mortality in the US
W Underwood et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2006)
Clinical decisions for treatment of different staged bladder cancer based on multitarget fluorescence in situ hybridization assays?
F. Steffen Krause et al.
WORLD JOURNAL OF UROLOGY (2006)
Multicolor fluorescence in situ hybridization (M-FISH) on cells from urine for the detection of bladder cancer
K. Junker et al.
CYTOGENETIC AND GENOME RESEARCH (2006)
Bladder tumor markers beyond cytology:: International consensus panel on bladder tumor markers
VB Lokeshwar et al.
UROLOGY (2005)
Fluorescence in situ hybridization for detecting transitional cell carcinoma:: implications for clinical practice
J Laudadio et al.
BJU INTERNATIONAL (2005)
NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer:: results from the Spanish Bladder Cancer Study and meta-analyses
M García-Closas et al.
LANCET (2005)
Effects of N-acetyl transferase 1 and 2 polymorphisms on bladder cancer risk in Caucasians
J Gu et al.
MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS (2005)
Monitoring intravesical therapy for superficial bladder cancer using fluorescence in situ hybridization
BR Kipp et al.
JOURNAL OF UROLOGY (2005)
ImmunoCyt/uCyt plus (TM) improves the sensitivity of urine cytology in patients followed for urothelial carcinoma
B Tetu et al.
MODERN PATHOLOGY (2005)
Intermediate-risk urothelial carcinoma: An unresolved problem?
A Pycha et al.
UROLOGY (2004)
Survival experience of black patients and white patients with bladder carcinoma
GR Prout et al.
CANCER (2004)
Multitarget fluorescence in situ hybridization assay detects transitional cell carcinoma in the majority of patients with bladder cancer and atypical or negative urine cytology
M Skacel et al.
JOURNAL OF UROLOGY (2003)
Immunocyt test improves the diagnostic accuracy of urinary cytology: Results of a french multicenter study
C Pfister et al.
JOURNAL OF UROLOGY (2003)
Role of uCyt plus in the detection and surveillance of urothelial carcinoma
M Lodde et al.
UROLOGY (2003)
Clinical evaluation of a multi-target fluorescent in situ hybridization assay for detection of bladder cancer
MF Sarosdy et al.
JOURNAL OF UROLOGY (2002)
The sex hormone receptors in the bladder in childhood I:: Preliminary report in male subjects
S Celayir et al.
EUROPEAN JOURNAL OF PEDIATRIC SURGERY (2002)
Four bladder tumor markers have a disappointingly low sensitivity for small size and low grade recurrence
H Boman et al.
JOURNAL OF UROLOGY (2002)
A comparison of urinary nuclear matrix protein-22 and bladder tumour antigen tests with voided urinary cytology in detecting and following bladder cancer: the prognostic value of false-positive results
V Poulakis et al.
BJU INTERNATIONAL (2001)
Comparative predictive values of urinary cytology, urinary bladder cancer antigen, CYFRA 21-1 and NMP22 for evaluating symptomatic patients at risk for bladder cancer
M Sánchez-Carbayo et al.
JOURNAL OF UROLOGY (2001)
Current bladder tumor tests: Does their projected utility fulfill clinical necessity?
VB Lokeshwar et al.
JOURNAL OF UROLOGY (2001)
Evaluation of asymptomatic microscopic hematuria in adults: The American Urological Association Best Practice Policy - Part I: Definition, detection, prevalence, and etiology
GD Grossfeld et al.
UROLOGY (2001)
Urine based markers of urological malignancy
BR Konety et al.
JOURNAL OF UROLOGY (2001)
A comparison of cytology and fluorescence in situ hybridization for the detection of urothelial carcinoma
KC Halling et al.
JOURNAL OF UROLOGY (2000)
The development of a multitarget, multicolor fluorescence in situ hybridization assay for the detection of urothelial carcinoma in urine
IA Sokolova et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2000)
Comparative evaluation of the BTAstat test, NMP22, and voided urine cytology in the detection of primary and recurrent bladder tumors
A Giannopoulos et al.
UROLOGY (2000)
Application of human complement factor H-related protein (BTA TRAK) in monitoring patients with bladder cancer
SB Malkowicz
UROLOGIC CLINICS OF NORTH AMERICA (2000)
分享论文
